Slavica Bobic

Rheumatology

710 94th Ave N Ste 307
Saint Petersburg, FL 33702

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1 publications

Use of B lymphocyte stimulator inhibitor belimumab may be associated with a decrease in the serum concentration of epidermal growth factor in patients with primary Sjögren's syndrome.

Use of B lymphocyte stimulator inhibitor belimumab may be associated with a decrease in the serum concentration of epidermal growth factor in patients with primary Sjögren's syndrome.

Journal: Clinical rheumatology

Published: September 25, 2014

Showing 1-1 of 1

Last Updated: 09/26/2026